Navigation Links
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
Date:7/22/2013

an> and Aliso Viejo, California, and San Jose, Costa Rica.  MicroVention is a developer, manufacturer and marketer of innovative neuroendovascular technologies for the treatment of vascular diseases in small vessels.  MicroVention products are sold throughout the world in more than 62 countries.  For more information, visit www.microvention.com.

About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $4 billion in sales and operations in more than 160 nations.  Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.  Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve.  Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.

Media Contact:
Cathy Demyanovich
Director, Corporate Communications
MicroVention. Inc.
800-990-8361
714-247-8000


'/>"/>
SOURCE MicroVention, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MicroVentions New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony
2. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
3. Kinex Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel that is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US
4. ANI Pharmaceuticals, Inc. Announces Date for Second Quarter 2013 Earnings Release
5. QRxPharma Announces Collaboration With Aesica
6. FDAnews Announces Leading the Climb: Seven Essentials of GMP Workshop
7. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
8. HemoShear Announces Advancement of Predictive Drug Safety Systems
9. Cardium Announces Reverse Stock Split
10. STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast
11. RXi Pharmaceuticals Announces CEO Interview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... DEERFIELD, Ill. , Aug. 21, 2014 /PRNewswire/ ... reports Baxter International Inc. today announced positive results ... BAX 855, an investigational, extended half-life recombinant factor ... ADVATE [Antihemophilic Factor (Recombinant)], which met its primary ... the prophylaxis arm compared to the on-demand arm. ...
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe customer ... , Managing Partner and Healthcare Industry Group Leader, has ... which recognizes the most inspiring people in the life-sciences ... in research and development, marketing, technology, creativity, strategy and ... 2006 as a partner in its leading Rosetta Consulting ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Shannon Hartley Shines in PharmaVOICE 100 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
(Date:8/22/2014)... News) -- Back-to-school time provides an opportunity for parents ... family schedules, an expert suggests. "Forget New Year,s ... also be the start of a new fitness and ... kinesiology at the University of the Sciences in Philadelphia, ... extracurricular activities likely to build up, "it,s important for ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 A national leader ... into new offices with room to grow. , Headquarters for ... to a 60,000-square-foot office building at 8516 N.W. Expressway in ... named one of the Oklahoma’s best places to work by ... The company has hired 120 in the past two years, ...
(Date:8/22/2014)... 22, 2014 Menstrual leaks risk stains ... Sunrise, Fla., decided that there needed to be a ... use and producible in design variations, the Safety Net ... leaks, which avoids embarrassment and promotes peace of mind. ... pads. , The original design was submitted to the ...
(Date:8/22/2014)... Counseling may do little to help young people with ... 66 studies that included nearly 18,000 people 25 and ... drinking problems. Participants in 49 studies attended a single ... the studies attended group sessions or a mix of ... motivational interviewing was used in the studies. This technique ...
(Date:8/22/2014)... be a challenging time for young people, but there are ... most of their new life, an expert says. This ... learn to manage the temptations of new freedom," Luis Manzo, ... University in New York City, said in a university news ... College is a time when students transition to adulthood, and ...
Breaking Medicine News(10 mins):Health News:With Kids in School, Parents Can Work Out 2Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:College Prep 101 2
... cardiologists have uncovered how a specific protein,s previously unsuspected role ... diabetes. Investigators in the mouse study also have found a ... The new research, available online and published in the March ... was carried out in the laboratory of Dr. Joseph ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... U.S. federal judge to block a government mandate calling for ... they are determined to fight back and keep the rule ... we can to warn young people about the dangers of ...
... Reinberg HealthDay Reporter , THURSDAY, March 1 (HealthDay ... cutting their risk of developing the deadly skin cancer melanoma, ... vitamin A called retinol could be a protective agent against ... researchers say. "We found a protective effect from supplemental ...
... years after the first sulfa drugs helped to revolutionize ... Children,s Research Hospital scientists have determined at an atomic ... The discovery provides the basis for a new generation ... to resist and cause fewer side effects. The ...
... Winship Cancer Institute of Emory University have identified a new ... cancer. Scientists had known that the gene, which encodes ... control proliferation and division. A team led by Erwin Van ... the process by which growing cancers attract new blood vessels. ...
... and surgeons are among the first in the nation ... injecting an investigational viral vector into their tumor. The ... Company, Tocagen Inc. "This clinical trial targets glioblastoma ... said principal investigator Santosh Kesari, MD, PhD, director of ...
Cached Medicine News:Health News:Cardiologists identify mechanism that makes heart disease worse in diabetics 2Health News:U.S. Will Push to Have Graphic Warnings on Cigarettes 2Health News:U.S. Will Push to Have Graphic Warnings on Cigarettes 3Health News:Vitamin A Supplements Might Cut Melanoma Risk: Study 2Health News:Vitamin A Supplements Might Cut Melanoma Risk: Study 3Health News:Solving mystery of how sulfa drugs kill bacteria yields 21st century drug development target 2Health News:Solving mystery of how sulfa drugs kill bacteria yields 21st century drug development target 3Health News:New pathway found for regulation of blood vessel growth in cancer 2Health News:UC San Diego among first in nation to treat brain cancer with novel viral vector 2
... and helix provide distal shaft column ... Construction eliminates springback and provides for ... to provide a better fit for ... ,Trimmable ends provide a custom ...
... The AMS 650™ and 600M™ malleable penile ... patientsespecially those with limited dexterity. These implants ... the patient to position them in an ... the penis rigid enough for sexual intercourse ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: